Pediatric Health Care Products and Services

Report Code: HLC059A

Publish Date: Mar 2009

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global pediatric healthcare market was worth $56.9 billion in 2008. This should reach $80.0 billion in 2013, for a compound annual growth rate (CAGR) of 7.2%.
The chronic illnesses segment generated nearly $39.0 billion in 2008. This is expected to grow at a CAGR of 8.7% to reach $59.3 billion in 2013.
The short-term illnesses segment generated $17.9 billion in 2008. This segment should increase to $19.9 billion in 2013, for a CAGR of 2.2%.

INTRODUCTION

STUDY GOAL AND OBJECTIVES

The aim of this study is to provide an in-depth analysis and forecast of the pediatric healthcare market. The focus is on scope of the market, including short-term and chronic illnesses; products and procedures currently available; and research regarding future treatments such as pharmaceuticals, diagnostics, and therapies.

REASONS FOR DOING THE STUDY

Children often suffer from acute short-term illnesses such as chronic upper respiratory or ear infections, gastrointestinal illness accompanied by vomiting and diarrhea, or injury-related problems. Some children, however, develop significant chronic illnesses that last for years or for their lifetimes. Some result from genetic or inherited conditions, others from environmental factors. Prenatal care for the mother and fetus is especially important as exposure to tobacco smoke, alcohol, and other toxins can significantly affect a baby’s health.

Pediatricians are confronted with a variety of short-term illnesses such as upper respiratory infections, ear infections, and gastrointestinal illnesses on a daily basis. While these illnesses are transient in nature, they also present a significant drain on time and financial resources for parents and others involved with the primary care of the child.

While most short-term illnesses are treatable and subside within 1 to 5 days, chronic illnesses are far more costly and damaging for the children, their families, and other caregivers. Chronic illnesses covered in this report include respiratory illnesses such as asthma and allergies; cystic fibrosis; diabetes; obesity; malnutrition; cerebral palsy; neurological illnesses such as attention deficient/hyperactivity disorder (ADHD), depression, and epilepsy/seizures; as well as illnesses as a consequence of low birth weight.

The report will investigate the market for treatments of acute short-term illnesses such as colds and flu, including prescription and over-the-counter medications and immunizations, and it will investigate the most significant chronic illnesses in the pediatric population. Treatment protocols and markets for products and services for each condition will be reported. The report will also identify the implications for chronic pediatric illnesses within various ethnicities including the African-American, Hispanic, and Asian communities.

Emerging technologies may be includedin the study if they appeared to be commercially significant by 2008.

INTENDED AUDIENCE

This study provides a broad background on the structure of the pediatric healthcare market and the chief issues it faces. It offers the information needed to understand the current market and to address the emerging one.

This is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investor consultants, and others interested in the pediatric healthcare market, its products, participants, and future.

SCOPE OF REPORT

This report offers forecasts—by product segment—from 2008 through 2013, including supporting analyses for projections. Projections are presented in constant 2008 U.S. dollars.

Product segments covered consist of respiratory, neurological, and gastrointestinal areas, including the pharmaceuticals that accompany each market. Products within the pharmaceutical pipeline and research into alternative treatment modalities such as herbal formulations are also included. International markets are discussed, and information is provided on industry structure.

Profiles of leading companies involved with pediatric care are provided. Information on company placement within the market and strategic analyses of the company’s available and emerging products is discussed.

INFORMATION SOURCES

Both primary and secondary research sources were used in preparing this research report, including an extensive literature review of medical and governmental sources; information from industry representatives, government personnel, and scientists within companies developing and marketing products; U.S. government data; industry professional organizations; and company reports.

Information for this report was obtained from industry analysts; the Center for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH), the Centers for Disease Control (CDC), and other government agencies; the American Association of Pediatricians; the American Association of Physician Assistants; the American Medical Association; the World Health Organization (WHO); literature searches; company annual reports and 10Ks; and product literature.

ANALYST'S CREDENTIALS

Peggy. S. Lehr is the BCC Research analyst of this report. Ms. Lehr has worked with nursing and medical not-for-profit organizationa and for-profit business publications. She specialized in marketing reports for the medical industry. Previous reports for BCC Research include market research reports that covered medical diagnostic kits, and organ and tissue transplantation.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com

[+] Show Chapter Details

Title/Chapter Name	Pages	Member Price
Full Report: Pediatric Health Care Products and Services	214	Free
Chapter- 1: INTRODUCTION	4	Free
STUDY GOAL AND OBJECTIVES REASONS FOR DOING THE STUDY INTENDED AUDIENCE SCOPE OF REPORT INFORMATION SOURCES ANALYST's CREDENTIALS RELATED BCC PUBLICATIONS BCC ONLINE SERVICES DISCLAIMER
Chapter- 2: SUMMARY	5	Free
PROJECTED GROWTH OF PEDIATRIC MARKETS MARKET FORECASTS FOR SHORT-TERM ILLNESSES MARKET FORECASTS FOR CHRONIC ILLNESSES
Chapter- 3: OVERVIEW OF THE PEDIATRIC HEALTHCARE INDUSTRY	10	Free
PRENATAL CARE/IMPLICATIONS NEWBORN CARE CHILDREN AGE 1 TO 6 CHILDREN AGE 7 TO 12 ADOLESCENT CHILDREN AGE 13 TO 18 ADOLESCENT REPRODUCTIVE HEALTH VACCINES/IMMUNIZATIONS IMPLICATIONS FOR FUTURE DEVELOPMENTS IN THE U.S. Table 1 : PROJECTED PEDIATRIC PREVENTATIVE CARE COSTS FROM BIRTH THROUGH AGE 18 IN THE U.S., THROUGH 2013
Chapter- 4: SHORT-TERM ILLNESSES IN THE PEDIATRIC POPULATION	20	Free
OTITIS MEDIA (EAR INFECTIONS) GASTROINTESTINAL ILLNESSES UPPER RESPIRATORY INFECTIONS Table 5 : GLOBAL COSTS OF THREE PRIMARY SHORT-TERM ILLNESSES IN PEDIATRIC POPULATION, THROUGH 2013 Figure 1 : GLOBAL COST OF PEDIATRIC SHORT-TERM ILLNESS, 2008 AND 2013
Chapter- 5: CHRONIC ILLNESSES IN THE PEDIATRIC POPULATION	105	Free
CYSTIC FIBROSIS DIABETES LOW-BIRTH WEIGHT MALNUTRITION NEUROLOGICAL DISORDERS ATTENTION DEFICIT DISORDER/ATTENTION DEFICIT HYPERACTIVITY DISORDER AUTISM SPECTRUM DISORDERS CEREBRAL PALSY DEPRESSION EPILEPSY/SEIZURES OBESITY RESPIRATORY ILLNESSES ALLERGIES ASTHMA Table 18 : GLOBAL COST OF CHRONIC ILLNESSES IN THE PEDIATRIC POPULATION, THROUGH 2013 Table 19 : COST OF CHRONIC ILLNESSES IN U.S. PEDIATRIC POPULATION, THROUGH 2013 Figure 2 : PROJECTED COSTS FOR PEDIATRIC CHRONIC ILLNESSES IN THE U.S., THROUGH 2013
Chapter- 6: CURRENT RESEARCH	23	Free
ALLERGIES ASTHMA ATTENTION DEFICIT/ATTENTION DEFICIT HYPERACTIVITY DISORDER CEREBRAL PALSY CYSTIC FIBROSIS DEPRESSION DIABETES EAR INFECTIONS EPILEPSY/SEIZURES OBESITY
Chapter- 7: C. CRAMER & CO. GMBH	47	Free
7TM PHARMA A/S ABBOTT ALTUS PHARMACEUTICALS ARADIGM CORPORATION ARENA PHARMACEUTICALS ASTRAZENECA AVONTEC GMBH AXCAN PHARMA USA BAYER AG (MILES-BAYER) CHIESI FARMACEUTICI S.P.A COPERNICUS THERAPEUTICS INC. COROMED INC. ELI LILLY EURAND PHARMACEUTICALS GENENTECH INC. GENEREX BIOTECHNOLOGY GILEAD SCIENCES INC. GSK PLC. INSPIRE PHARMACEUTICALS INC. JOHNSON & JOHNSON SERVICES INC. KALOBIOS PHARMACEUTICALS INC. LANTIBIO INC. MANNKIND CORP. MAP PHARMAEUTICALS MERCK & CO INC. NOVARTIS AG NOVO NORDISK A/S NUTRISET PFIZER INC. PHARMAXIS LTD. PHYTOPHARM, PLC PTC THERAPEUTICS ROCHE PHARMACEUTICALS SANOFI-AVENTIS SCHERING-PLOUGH SEPRACOR SHIRE U.S. SOLVAY PHARMACEUTICALS SUCAMPO PHARMACEUTICALS SYNAIRGEN PLC TOPIGEN PHARMACEUTICALS INC. UCB PHARMACEUTICALS VECTURA GROUP PLC VERTEX PHARMACEUTICALS INC. WYETH APPENDIX: SELECTED PEDIATRIC PRODUCTS BY ILLNESS

Related Reports

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Flame Retardant Chemicals: Technologies and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - CHM014Q

The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.

Biorefinery Products: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - EGY117D

The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Electric Vehicle Charging: Infrastructure and Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - FCB045B

The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Pediatric Health Care Products and Services

Report Highlights

Table of Contents

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight